Zobrazeno 1 - 10 of 305 pro vyhledávání: '"Hammon K"'
1
Akademický článek
D-2-hydroxyglutarate supports a tolerogenic phenotype with lowered major histocompatibility class II expression in non-malignant dendritic cells and acute myeloid leukemia cells.
Autor: Hammon K; Department of Internal Medicine III, University Hospital Regensburg; Regensburg, Germany; LIT - Leibniz Institute for Immunotherapy; Regensburg., Renner K; Department of Internal Medicine III, University Hospital Regensburg; Regensburg, Germany; LIT - Leibniz Institute for Immunotherapy; Regensburg, Germany; Department of Otorhinolaryngology, University Hospital Regensburg, Regensburg., Althammer M; Department of Internal Medicine III, University Hospital Regensburg; Regensburg., Voll F; LIT - Leibniz Institute for Immunotherapy; Regensburg., Babl N; Department of Internal Medicine III, University Hospital Regensburg; Regensburg., Decking SM; Department of Otorhinolaryngology, University Hospital Regensburg, Regensburg., Siska PJ; Department of Internal Medicine III, University Hospital Regensburg; Regensburg., Matos C; Department of Internal Medicine III, University Hospital Regensburg; Regensburg., Conejo ZEC; Department of Internal Medicine III, University Hospital Regensburg; Regensburg., Mendes K; Department of Internal Medicine III, University Hospital Regensburg; Regensburg, Germany; Present address: Universidade Católica Portuguesa, Center for Interdisciplinary Research in Health (CIIS), Institute of Health Sciences (ICS); Viseu., Einwag F; Department of Internal Medicine III, University Hospital Regensburg; Regensburg., Siegmund H; Institute of Pathology, University of Regensburg; Regensburg., Iberl S; Department of Internal Medicine III, University Hospital Regensburg; Regensburg., Berger RS; Institute of Functional Genomics, University of Regensburg; Regensburg., Dettmer K; Institute of Functional Genomics, University of Regensburg; Regensburg., Schoenmehl R; Institute of Pathology, University Medical Center Mannheim, University Heidelberg, Mannheim., Brochhausen C; Institute of Pathology, University of Regensburg; Regensburg, Germany; Institute of Pathology, University Medical Center Mannheim, University Heidelberg, Mannheim., Herr W; Department of Internal Medicine III, University Hospital Regensburg; Regensburg., Oefner PJ; Institute of Functional Genomics, University of Regensburg; Regensburg., Rehli M; Department of Internal Medicine III, University Hospital Regensburg; Regensburg, Germany; LIT - Leibniz Institute for Immunotherapy; Regensburg., Thomas S; Department of Internal Medicine III, University Hospital Regensburg; Regensburg, Germany; LIT - Leibniz Institute for Immunotherapy; Regensburg., Kreutz M; Department of Internal Medicine III, University Hospital Regensburg; Regensburg, Germany; LIT - Leibniz Institute for Immunotherapy; Regensburg. marina.kreutz@ukr.de.
Publikováno v: Haematologica [Haematologica] 2024 Aug 01; Vol. 109 (8), pp. 2500-2514. Date of Electronic Publication: 2024 Aug 01.
Zobrazit plný text záznamu
2
Akademický článek
Ultra-sensitive AAV capsid detection by immunocapture-based qPCR following factor VIII gene transfer.
Autor: Sandza K; BioMarin Pharmaceutical, Inc., Novato, CA, USA., Clark A; BioMarin Pharmaceutical, Inc., Novato, CA, USA., Koziol E; BioMarin Pharmaceutical, Inc., Novato, CA, USA., Akeefe H; BioMarin Pharmaceutical, Inc., Novato, CA, USA., Yang F; BioMarin Pharmaceutical, Inc., Novato, CA, USA., Holcomb J; BioMarin Pharmaceutical, Inc., Novato, CA, USA., Patton K; BioMarin Pharmaceutical, Inc., Novato, CA, USA., Hammon K; BioMarin Pharmaceutical, Inc., Novato, CA, USA., Mitchell N; BioMarin Pharmaceutical, Inc., Novato, CA, USA., Wong WY; BioMarin Pharmaceutical, Inc., Novato, CA, USA., Zoog SJ; BioMarin Pharmaceutical, Inc., Novato, CA, USA., Kim B; BioMarin Pharmaceutical, Inc., Novato, CA, USA., Henshaw J; BioMarin Pharmaceutical, Inc., Novato, CA, USA., Vettermann C; BioMarin Pharmaceutical, Inc., Novato, CA, USA. christian.vettermann@bmrn.com.
Publikováno v: Gene therapy [Gene Ther] 2022 Feb; Vol. 29 (1-2), pp. 94-105. Date of Electronic Publication: 2021 Aug 23.
Zobrazit plný text záznamu
3
Akademický článek
Anti-Thymocyte Globulin Treatment Augments 1,25-Dihydroxyvitamin D3 Serum Levels in Patients Undergoing Hematopoietic Stem Cell Transplantation.
Autor: Matos C; Department of Internal Medicine III, University Hospital Regensburg, Regensburg, Germany., Peter K; Department of Internal Medicine III, University Hospital Regensburg, Regensburg, Germany., Weich L; Department of Internal Medicine III, University Hospital Regensburg, Regensburg, Germany., Peuker A; Department of Internal Medicine III, University Hospital Regensburg, Regensburg, Germany., Schoenhammer G; Department of Internal Medicine III, University Hospital Regensburg, Regensburg, Germany., Roider T; Department of Internal Medicine III, University Hospital Regensburg, Regensburg, Germany.; Department of Medicine V, University of Heidelberg, Heidelberg, Germany., Ghimire S; Department of Internal Medicine III, University Hospital Regensburg, Regensburg, Germany., Babl N; Department of Internal Medicine III, University Hospital Regensburg, Regensburg, Germany., Decking S; Department of Internal Medicine III, University Hospital Regensburg, Regensburg, Germany.; Regensburg Center for Interventional Immunology (RCI), Regensburg, Germany., Güllstorf M; Department of Stem Cell Transplantation, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Kröger N; Department of Stem Cell Transplantation, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Hammon K; Regensburg Center for Interventional Immunology (RCI), Regensburg, Germany., Herr W; Department of Internal Medicine III, University Hospital Regensburg, Regensburg, Germany., Stark K; Department for Genetic Epidemiology, University of Regensburg, Regensburg, Germany., Heid IM; Department for Genetic Epidemiology, University of Regensburg, Regensburg, Germany., Renner K; Department of Internal Medicine III, University Hospital Regensburg, Regensburg, Germany., Holler E; Department of Internal Medicine III, University Hospital Regensburg, Regensburg, Germany., Kreutz M; Department of Internal Medicine III, University Hospital Regensburg, Regensburg, Germany.
Publikováno v: Frontiers in immunology [Front Immunol] 2022 Jan 04; Vol. 12, pp. 803726. Date of Electronic Publication: 2022 Jan 04 (Print Publication: 2021).
Zobrazit plný text záznamu
4
Akademický článek
Dose selection for intracerebroventricular cerliponase alfa in children with CLN2 disease, translation from animal to human in a rare genetic disease.
Autor: Hammon K; BioMarin Pharmaceutical Inc., Novato, California, USA., de Hart G; BioMarin Pharmaceutical Inc., Novato, California, USA., Vuillemenot BR; BioMarin Pharmaceutical Inc., Novato, California, USA., Kennedy D; BioMarin Pharmaceutical Inc., Novato, California, USA., Musson D; BioMarin Pharmaceutical Inc., Novato, California, USA., O'Neill CA; BioMarin Pharmaceutical Inc., Novato, California, USA., Katz ML; Mason Eye Institute, University of Missouri School of Medicine, Columbia, Missouri, USA.; Department of Bioengineering, University of Missouri, Columbia, Missouri, USA., Henshaw JW; BioMarin Pharmaceutical Inc., Novato, California, USA.
Publikováno v: Clinical and translational science [Clin Transl Sci] 2021 Sep; Vol. 14 (5), pp. 1810-1821. Date of Electronic Publication: 2021 Jun 02.
Zobrazit plný text záznamu
5
Akademický článek
Human platelet antigen genotypes in Turkish and Caucasian blood donors in Germany.
Autor: Hauck-Dlimi, B.1, Hammon, K.1, Eckstein, R.1, Ott, S.1, Zimmermann, R.1, Dengler, T.2, Ringwald, J.1
Publikováno v: Tissue Antigens. Sep2012, Vol. 80 Issue 3, p214-218. 5p.
Zobrazit plný text záznamu
6
Akademický článek
Clinical Pharmacokinetics and Pharmacodynamics of Cerliponase Alfa, Enzyme Replacement Therapy for CLN2 Disease by Intracerebroventricular Administration.
Autor: Kim A; BioMarin Pharmaceutical Inc., Novato, California, USA., Grover A; BioMarin Pharmaceutical Inc., Novato, California, USA., Hammon K; BioMarin Pharmaceutical Inc., Novato, California, USA., de Hart G; BioMarin Pharmaceutical Inc., Novato, California, USA., Slasor P; BioMarin Pharmaceutical Inc., Novato, California, USA., Cherukuri A; BioMarin Pharmaceutical Inc., Novato, California, USA., Ajayi T; BioMarin Pharmaceutical Inc., Novato, California, USA., Jacoby D; BioMarin Pharmaceutical Inc., Novato, California, USA., Schulz A; University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Specchio N; Bambino Gesù Children's Hospital IRCCS, Rome, Italy., de Los Reyes E; Nationwide Children's Hospital and Ohio State University, Columbus, Ohio, USA., Gissen P; NIHR Great Ormond Street Hospital Biomedical Research Centre, University College London, London, UK., Henshaw JW; BioMarin Pharmaceutical Inc., Novato, California, USA.
Publikováno v: Clinical and translational science [Clin Transl Sci] 2021 Mar; Vol. 14 (2), pp. 635-644. Date of Electronic Publication: 2020 Nov 30.
Zobrazit plný text záznamu
7
Akademický článek
Optimizing CD8+ T cell-based immunotherapy via metabolic interventions: a comprehensive review of intrinsic and extrinsic modulators.
Autor: Zhou, Zihao1 (AUTHOR), Zheng, Jiarong2 (AUTHOR), Lu, Ye1 (AUTHOR), Mai, Zizhao1 (AUTHOR), Lin, Yunfan1 (AUTHOR), Lin, Pei1 (AUTHOR), Zheng, Yucheng1 (AUTHOR), Chen, Xu1 (AUTHOR), Xu, Rongwei1 (AUTHOR), Zhao, Xinyuan1 (AUTHOR) zhaoxinyuan1989@smu.edu.cn, Cui, Li1,3 (AUTHOR) licui@smu.edu.cn
Publikováno v: Experimental Hematology & Oncology. 10/22/2024, Vol. 13 Issue 1, p1-21. 21p.
Zobrazit plný text záznamu
8
Akademický článek
HLA-DPB1 Reactive T Cell Receptors for Adoptive Immunotherapy in Allogeneic Stem Cell Transplantation.
Autor: Klobuch S; Department of Internal Medicine III, University Hospital Regensburg, 93042 Regensburg, Germany., Hammon K; Department of Internal Medicine III, University Hospital Regensburg, 93042 Regensburg, Germany.; Regensburg Center for Interventional Immunology, University of Regensburg, 93042 Regensburg, Germany., Vatter-Leising S; Department of Internal Medicine III, University Hospital Regensburg, 93042 Regensburg, Germany., Neidlinger E; Department of Internal Medicine III, University Hospital Regensburg, 93042 Regensburg, Germany., Zwerger M; Department of Internal Medicine III, University Hospital Regensburg, 93042 Regensburg, Germany., Wandel A; Department of Internal Medicine III, University Hospital Regensburg, 93042 Regensburg, Germany., Neuber LM; Department of Internal Medicine III, University Hospital Regensburg, 93042 Regensburg, Germany., Heilmeier B; Department of Oncology and Hematology, Hospital Barmherzige Brueder, 93049 Regensburg, Germany., Fichtner R; Department of Internal Medicine III, University Hospital Regensburg, 93042 Regensburg, Germany., Mirbeth C; Department of Internal Medicine III, University Hospital Regensburg, 93042 Regensburg, Germany., Herr W; Department of Internal Medicine III, University Hospital Regensburg, 93042 Regensburg, Germany., Thomas S; Department of Internal Medicine III, University Hospital Regensburg, 93042 Regensburg, Germany.; Regensburg Center for Interventional Immunology, University of Regensburg, 93042 Regensburg, Germany.
Publikováno v: Cells [Cells] 2020 May 20; Vol. 9 (5). Date of Electronic Publication: 2020 May 20.
Zobrazit plný text záznamu
9
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
10
Akademický článek
Divergent Processing of Cell Stress Signals as the Basis of Cancer Progression: Licensing NFκB on Chromatin.
Autor: Vlahopoulos, Spiros A.1 (AUTHOR) sblachop@med.uoa.gr
Publikováno v: International Journal of Molecular Sciences. Aug2024, Vol. 25 Issue 16, p8621. 29p.
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje